NCR2 and neoplasm: Once NK cells are recruited into the tumor microenvironment, NK activating NKp46, NKp30, NKp44, NKG2D and inhibiting KIR, NKG2A receptors can recognize and be activated by tumor cells (9, 10), leading to NK cell mediated cytotoxicity.